Sutro Biopharma, Inc. (FRA:S090)
Germany · Delayed Price · Currency is EUR 6.78
-0.41 (-5.70%)
At close: Dec 2, 2025
Sutro Biopharma Market Cap
Sutro Biopharma has a market cap or net worth of €63.38 million as of December 5, 2025. Its market cap has decreased by -69.86% in one year.
Market Cap
63.38M
Enterprise Value
-65.51M
Revenue
90.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.78
Market Cap Chart
Since September 27, 2018, Sutro Biopharma's market cap has decreased from 297.24M to 63.38M, a decrease of -78.68%. That is a compound annual growth rate of -19.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 63.38M | -56.75% |
| Dec 31, 2024 | 146.55M | -38.05% |
| Dec 29, 2023 | 236.57M | -45.56% |
| Dec 30, 2022 | 434.54M | -28.22% |
| Dec 31, 2021 | 605.40M | -25.04% |
| Dec 31, 2020 | 807.60M | 256.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 97.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.46B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |